GSK Plc is “betting big on the US” and engaged in constructive talks on drug pricing with US President Donald Trump’s administration, according to Emma Walmsley, the outgoing chief executive officer ...

Walmsley, who helped push GSK to focus more exclusively on specialty medicines and oncology, will be succeeded by commercial ...

GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on ...

GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more ...

Emma Walmsley, who in 2017 became the first woman to lead a major pharmaceutical company, will step down from her post as CEO ...

GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the ...

Walmsley will step down from the board of directors of GSK at the end of the year, and will step down as CEO on 30th ...

GSK has announced the departure of the pharmaceutical group’s first female chief executive, Dame Emma Walmsley after eight ...

Nearly nine years ago, when Emma Walmsley was preparing to take over as CEO of GSK Plc, she wrote in her diary that Luke ...

Emma Walmsley was the first woman to hold the CEO post at the Big Pharma company.

Chief executive Emma Walmsley is to leave GSK, it was announced on Monday, after nearly a decade in the role. She will be ...

GSK is "betting big on the US" and engaged in "constructive" talks on drug pricing with President Donald Trump's ...